Microglial cerebrospinal fluid antibodies

Significance for alzheimer disease
  • Amanda McRae
  • Eng Ang Ling
  • Annelie Wigander
  • Annica Dahlström
Part IV Immune Mechanisms in Neurodegenerative and Neuropsychiatric Disorders


Hallmark lesions of Alzheimer disease (AD) are filled with reactive immunocompetent microglia, suggesting that immunological aderrations may participate in the pathophysiology of this disorder. If immune-mediated processes are closely linked to neuronal break-down, it would be of importance to have a reliable means to detect these processes. Cerebrospinal fluid (CSF) antibodies are discussed as such potential sources. The seredipitous use of the developing rat central nervous system (CNS) unexpectedly demonstrated that some AD CSF recognize amoeboid microglial cells. Similarly, AD CSF specifically stains activated microglia and neural macrophages in experimentally induced lesions. A cell-culture technique is described that allows rapid screening of CSF antibodies. Examination of CSF from a diversified dementia population revealed that AD CSF, in contrast to other dementia CSF, displayed remarkable selectivity toward microglial cells. Cortical biopsies from patients suspected to have AD were incubated with the patient's own CSF and that of confirmed AD patients. Both CSF samples recognized microglial cells in the cortical biopsy. AD CSF microglial antibodies appear to be significant in view of the increasing association between microglia and neuro degenerative processes in AD. These findings add further support to the concept that inflammation and similar immune mechanisms may contribute to to AD pathogenesis.

Index Entries

Alzheimer disease microglia diagnosis rat brain cerebrospinal fluid antibodies immune responses 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baldinger S. and Blumenthal H. T. (1982) Neuroimmunology of the aging brain, inGeriatrics (Platt D, ed.), Springer Verlag, Berlin, Germany, pp. 283–299.Google Scholar
  2. Banati R. B., Schubert P., Rothe G., Gehrmann J., Rudolphi K., Valet G., and Kreutzberg G. W. (1994) Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by propentofylline.J. Cereb. Blood Flow Metab. 14, 145–149.PubMedGoogle Scholar
  3. Cras P., Kawai M., Siedlak S., and Perry G. (1991) Microglia are associated the extracellular neurofibrillary tangles of Alzheimer's disease.Brain Res. 558, 312–314.PubMedCrossRefGoogle Scholar
  4. Dahlström A., McRae A., Polinsky R., Nee L., Sadasivan B., and Ling E. A. (1994) Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia investigations with cell cultures and human cortical biopsies.Molecular Neurobiology 9, 41–54.PubMedCrossRefGoogle Scholar
  5. Dahlström A., Wigander A., Lundmark K., Gottfries C. G., and McRae A. (1990) Investigations on autoantibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures.J. Neural Trans. (suppl) 29, 195–206.Google Scholar
  6. Fudenberg H. H. and Singh V. (1988) Alzheimer's “Syndrome”: Prognosis of subsets with different etiology and preliminary effects of immunotherapy.Drug Dev. Res. 15, 165–174.CrossRefGoogle Scholar
  7. Guilian D. (1987) Ameoboid microglia as effectors of inflammation in the central nervous system.J. Neurosci. Res. 18, 155–171.CrossRefGoogle Scholar
  8. Haga S., Akai K., and Ishii T. (1989) Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody.Acta Neuropathol. 77, 569–575.PubMedCrossRefGoogle Scholar
  9. Ling E. A. and Wong W. C. (1993) The origin and nature of ramified and ameoboid microglia: A historical review and current concepts.Glia 7, 9–18.PubMedCrossRefGoogle Scholar
  10. Ling E. A., Kaur C., Yick T., and Wong W. (1990) Immunocytochemical localization of CR3 complement receptors with OX 42 in amoeboid microglia in postnatal rats.Anat. Embryol. 182, 481–486.PubMedGoogle Scholar
  11. Ling E. A., Dahlström A., Polinsky R., Nee L., and McRae A. (1992a) Studies of activated microglia cells and macrophages using Alzheimer's disease cerebrospinal fluid in adult rats with experimentally induced lesions.Neuroscience 51, 815–825.PubMedCrossRefGoogle Scholar
  12. Ling E. A., Kaur C., and Wong W. C. (1992b) Expression of major histocompatibility complex antigens and CR3 complement receptors in activated microglia following an injection of ricin into the sciatic nerve in rats.Histol. Histopath 7, 93–100.Google Scholar
  13. McGeer P. and Rogers J. (1992) Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease.Neurology 42, 447–449.PubMedGoogle Scholar
  14. McGeer P., Itagaki S., Tago H., and McGeer E. G. (1987) Reactive microglia in patients with senile dementia of the Alzheimer's type are positive for the histocompatibility glycoprotein HLA-DR.Neurosci. Lett. 79, 195–200.PubMedCrossRefGoogle Scholar
  15. McGeer P. L., Akiyama H., Itagaki S., and McGeer E. G. (1989) Immune system response in Alzheimer's disease.Can J. Neurol. Sci. 16, 516–527.PubMedGoogle Scholar
  16. McRae A., Blennon K., Gottfries C. G., Walin A., and Dahlström A. (1990) Brain specific antibodies in the CSF of patients with Alzheimer's disease and other types of dementias, inBiological Markers in Dementia of Alzheimer Type (Fowler C. J., Carlson L. A., Gottfries C. G., and Winblad B., eds.), Smith-Gordon, London, pp. 135–148.Google Scholar
  17. McRae A., Ling E. A., Polinsky R., Gottfries C. G., and Dahlström A. (1991) Antibodies in the cerebrospinal fluid of some Alzheimer's disease patients recognize amoeboid microglial cells in the developing rat central nervous system.Neuroscience 41, 739–752.PubMedCrossRefGoogle Scholar
  18. McRae A., Rudolphi K., and Keil M. (1993) Forebrain ischemia in monogolian gerbil: a model to investigate Alzheimer's disease microglial antibodies and amyloid,Soc. Neurosci. Abstract 19, 623.Google Scholar
  19. McRae A., Rudolphi K. A., and Schubert P. (1994) Propentofylline depresses amyloid and Alzheimer's CSF microglial antigens after ischemia,NeuroReport 5, 1193–1196.PubMedGoogle Scholar
  20. Morioka T., Kalehua A. N. and Streit W. J. (1992) Progressive expression of immunomolecules on microglial cells in rat dorsal hippocampus following transient forebrain ischemia,Acta Neuropathol. 83, 149–157.PubMedCrossRefGoogle Scholar
  21. Rio-Hertega P. del. (1932) Microglial, inCytology and Cellular Pathology of the Nervous System, Vol. 2 (Penfield W., ed.), Paul B Hoeber, New York, pp. 481–584.Google Scholar
  22. Rogers J., Luber-Narod J., Styren S., and Civin H. (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease.Neurobiol. Aging 9, 339–349.PubMedCrossRefGoogle Scholar
  23. Selkoe D., Ihara Y., and Salazar F. J. (1982) Alzheimer's disease: Insolubility of partially purified paired filaments helical in sodium dodecyl sulfate and urea.Science 215, 1243–1245.PubMedCrossRefGoogle Scholar
  24. Shu S., Ju G., and Fan L. (1988) The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system.Neurosci. Lett. 85, 169–171.PubMedCrossRefGoogle Scholar
  25. Wigander A., Lundmark K., McRae A., Dahlström A., and Ahlman H. (1989) Survival of rat fetal cholinergic neurons co-cultured with human midgut carcinoid tumour cells.Acta Scand. Physiol. 136, 291–292.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1996

Authors and Affiliations

  • Amanda McRae
    • 1
  • Eng Ang Ling
    • 2
  • Annelie Wigander
    • 1
  • Annica Dahlström
    • 1
  1. 1.Department of Anatomy and Cell BiologyGöteborgSweden
  2. 2.Department of AnatomyNational University of SingaporeSingapore

Personalised recommendations